Last reviewed · How we verify
NCT05031429: TLET1D
Time Limited Eating in Type 1 Diabetes
NA trial testing Time Limited Eating in Type 1 Diabetes in 12 participants. Completed in 30 June 2023.
13 June 2023
Quick facts
| Lead sponsor | Children's Hospital Los Angeles |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 12 |
| Start date | 1 January 2022 |
| Primary completion | 13 June 2023 |
| Estimated completion | 30 June 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Time Limited Eating
Conditions studied
- Type 1 Diabetes — all drugs for Type 1 Diabetes →
Sponsor
Children's Hospital Los Angeles
Who can join
Adults 12 to 25, any sex, with Type 1 Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a randomized-control pilot study that aims to evaluate Time Limited Eating (TLE) in the pediatric T1D population, implemented within the first six months after diagnosis. This period is characterized by residual β-cell function, during which TLE may have the ability to preserve and improve β-cell activity, indicated by increased C-peptide production. The investigators aim to assess the feasibility, acceptability, and safety of TLE in the pediatric T1D population, as well as to investigate the impact of TLE on β-cell function, insulin sensitivity, and glycemic control.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Time-restricted eating: Watching the clock to treat obesity.
Ezpeleta M, Cienfuegos S, Lin S, Pavlou V, et al · · 2024 · cited 83× · PMID 38176412 · DOI 10.1016/j.cmet.2023.12.004 -
Circadian rhythms and inflammatory diseases of the liver and gut.
Ferrell JM. · · 2023 · cited 7× · PMID 39958387 · DOI 10.1016/j.livres.2023.08.004
Verify or expand the search:
- PubMed search for NCT05031429
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Time Limited Eating
Trials testing the same drug.
- NCT04536480 — Time Limited Eating in Adolescents With Type 2 Diabetes (KT2D) · NA · recruiting
- NCT03954223 — Time Limited Eating in Adolescents (Time LEAd): a Pilot Study · NA · completed
Other recruiting trials for Type 1 Diabetes
Currently open trials in the same condition.
- NCT07061574 — A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New On · Phase 1, PHASE2 · recruiting
- NCT07360080 — Long-Term Outcomes of Teplizumab in Routine Clinical Care · recruiting
- NCT07457580 — Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs) · recruiting
- NCT07212179 — Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 · NA · recruiting
- NCT07287943 — To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes. · NA · recruiting
Other Children's Hospital Los Angeles trials
Trials by the same sponsor.
- NCT07064824 — Adaptive Cell Phone Support (ACPS) · NA · not yet recruiting
- NCT07508436 — Crisis Interventions for Pediatric Providers - Autism Version · NA · not yet recruiting
- NCT06934655 — Early Re-Initiation of Semaglutide Post Sleeve Gastrectomy in Youth · Phase 3 · not yet recruiting
- NCT07427862 — Virtual Reality (VR) for Interventional Radiology (IR) Procedures · recruiting
- NCT07213908 — Comparing Two School-Based Sleep Health Interventions To Promote Sleep Quality in Youth · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05031429 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Children's Hospital Los Angeles
- Last refreshed: 16 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05031429.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing